An updated systematic review with meta-analysis for the clinical evidence of silymarin.
about
Identification of hepatoprotective flavonolignans from silymarinThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsFree Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver DamageDistinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology.Optimization and single-laboratory validation of a method for the determination of flavonolignans in milk thistle seeds by high-performance liquid chromatography with ultraviolet detection.Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male miceFree Radical Scavenging and Antioxidant Activities of Silymarin Components.Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMilk thistle and its derivative compounds: a review of opportunities for treatment of liver disease.Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.Metabolic profile and hepatoprotective activity of the anthocyanin-rich extract of Hibiscus sabdariffa calyces.Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.Motivations for Botanical Use by Socioeconomically Diverse, Urban Adults: Does Evidence Support Motivation?Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.Multiple effects of silymarin on the hepatitis C virus lifecycle.Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysisHepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism.Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro.High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy.Citrus flavanones affect hepatic fatty acid oxidation in rats by acting as prooxidant agents.Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite, 9-hydroxyrisperidone in rats.Silibinin attenuates oxidative metabolism and cytokine production by monocytes from preeclamptic women.Catabolism of amino acids in livers from cafeteria-fed rats.Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.Phytotherapeutics: The Emerging Role of Intestinal and Hepatocellular Transporters in Drug Interactions with Botanical Supplements.Principles of pharmacological research of nutraceuticals.New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
P2860
Q24600492-31F5ADFD-CA78-4E3A-B581-0B195E5E77CEQ28066752-086B6D5A-DD83-4CEB-8BF7-AAA168A4D3D6Q28551489-F334797D-5AE5-4E52-A361-20B105FE4B52Q34027884-66219781-C6BB-4F90-B818-D39AF0A63260Q35734783-DC2BDFEC-D54B-4ECB-A872-A4FDA7D3A05DQ36073650-BA64F30E-3523-4EF5-A088-396E6D8D87DAQ36254212-C53737E8-6F6E-41CC-93CA-26C13481DB28Q36335116-05C3783B-739B-4123-BA5C-B137F61CBA38Q36675737-650F270D-106E-4344-B08F-DEC96D678DD5Q36933129-53D16269-B0F7-4027-929A-8330818FFC93Q38058825-D0D2B604-19B0-4350-B026-69AC07DA937FQ38341299-11180A2B-D7F5-4904-9CDE-81C5CDC2A0C0Q38827593-5F3F08AF-F4C3-4AEC-B055-137C97F1ED3BQ39104518-396D906B-DE2C-4099-9CB6-0AD76D409C8CQ39258614-A503F742-586B-43B1-8623-8CED5D74C47FQ39410047-5C19E55B-6569-4A57-B722-3C556138B107Q39698364-D91D0F4C-B7C6-4C58-8FB7-7EBF0B0C7DC3Q39777094-01463CAE-3B35-449A-94B6-E6CE5B3E8356Q41122488-5FC612C5-1162-4C2E-AC51-A3BB8DA2AA83Q41891908-E64C711F-0641-4686-B164-28D11EE63C0AQ42963759-B538FA4E-FB68-4CB1-A9BA-DFFA45C06A0BQ42981955-6754AC3B-76DD-49BE-898B-A06743FA5F53Q43655175-7114A27F-4C85-4E96-B918-3766DD7AEAB4Q44176429-8F840F8C-6AE2-4CD4-937D-1B30446BCDEFQ44553960-486866D6-C46B-48EE-B4CB-D6002A8ADBE7Q44651316-8D638A06-8D94-40A1-83B9-5084D7F13C12Q50071437-809DF634-8AC1-4C2C-B3A4-6F9A4B38B9FDQ50077257-930EE5A7-F18B-4338-A884-3477293E2B84Q55072787-EBC9B805-A980-43E6-81EA-AF5F2EEC3E4EQ57114860-3A6518CB-6215-4B45-B144-FAA470BB272F
P2860
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@ast
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@en
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@nl
type
label
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@ast
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@en
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@nl
prefLabel
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@ast
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@en
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@nl
P2093
P2860
P356
P1476
An updated systematic review with meta-analysis for the clinical evidence of silymarin.
@en
P2093
Jörg Melzer
Reinhard Saller
Reto Brignoli
Rémy Meier
P2860
P356
10.1159/000113648
P577
2008-02-01T00:00:00Z